Delivery Order SPE2DX22D0010-SPE2D825FJS38
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) on August 24, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,862.76 by the Defense Logistics Agency's Medical Supply Chain for the supply of OxyContin Tabs 20mg. The contract, awarded on June 1, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of OxyContin Tablets 30mg to the Defense Logistics Agency's Medical Supply Chain. The contract, valued at $1,541.40 with a firm fixed-price structure, carries an ultimate completion date of August 6, 2025, and will be fulfilled at the vendor's Conshohocken, PA facility. This delivery order was competitively awarded with no...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,007.92 on September 12, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is competitively awarded with no set-aside designation and features firm fixed pricing, with an ultimate completion date of September 15, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a division of the...
- The Defense Logistics Agency's Medical Supply Chain has awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) under a firm fixed-price contract. The award, made on August 31, 2025, with an ultimate completion date of September 2, 2025, represents a competitive, non-set-aside procurement for pharmaceutical supply to support military healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 3, 2025, for the supply of OxyContin tablets 20mg, with a ceiling value of $3,304.45. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 6, 2025, for the supply of OxyContin tablets (20mg) under a firm fixed-price contract with a ceiling value of $3,304.45. This non-set-aside delivery order represents a competitive award to the prime contractor and is scheduled for ultimate completion by July 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of OxyContin tablets 40mg, with a contract ceiling value of $2,508.63 and an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $5,025.57. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by August 12, 2025, with the product to be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJS38Delivery Order
AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency's Medical Supply Chain for OxyContin 20mg tablets with a ceiling value of $5,702.74. The contract, awarded on September 28, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price transaction with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to compete successfully for federal contracts, coupled with its substantial prime vendor status with DLA Troop Support Medical, positions it as a key supplier for Department of Defense pharmaceutical needs. This particular delivery order exemplifies the company's role in fulfilling ongoing medical supply requirements for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 9/28/25 |